1. Background
2. Objectives
3. Methods
3.1. Collection and Identification of Plant Material
3.2. Processing and Extraction of Plant Materials
3.3. Qualitative Determination of Phytochemicals Present in Citrus limon Juice and Newbouldia laevis Extracts
3.4. Biosynthesis of Silver Nanoparticles
3.5. Characterization of Biosynthesized Nanoparticles
3.6. Source of Bacterial Cultures
3.7. Antibiotic Susceptibility Test
3.8. Antibacterial Activity of Biosynthesized Silver Nanoparticles
3.9. Data Analysis
4. Results
4.1. Phytochemical Constituents of Citrus limon Juice and Newbouldia laevis Extracts
| Phytochemicals | Citrus limon Juice Extract | Newbouldia laevis Leaves |
|---|---|---|
| Flavonoids | + | - |
| Phenols | + | + |
| Alkaloids | + | - |
| Tannins | + | + |
| Steroids | + | + |
| Cardiac steroids | + | + |
| Glycosides | + | + |
| Volatile oil | + | - |
| Anthraquinone | + | - |
| Resins | + | + |
| Saponins | + | + |
| Terpenes | + | + |
| Reducing sugar | + | - |
a +, Positive; -, negative
4.2. Biosynthesis of Silver Nanoparticles
4.3. Characterization of Silver Nanoparticles
4.4. Morphology of Synthesized Plant Extract Cocktail-Mediated Silver Nanoparticles
4.5. Biochemical Characteristics of the Test Isolates
| G-R | Sh | Cat | Cit | Pig | Glu | Man | Indole | Urease | MR | VP | Lactose | H2S | Slant | Butt | Inference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | Rod | + | + | NA | + | + | - | + | - | + | + | - | NC | NC | Klebsiella pnuemoniae |
| + | Cocci | + | + | Yellow | - | - | - | + | NA | + | - | - | NA | NA | Micrococcus luteus |
| + | Rod | - | NA | + | - | - | - | NA | - | - | NA | NA | NA | Clostridium difficile | |
| - | Rod | + | - | NA | + | + | + | - | + | - | + | - | Acid | Acid | Escherichia coli |
Abbreviations: Sh, shape; Cat, catalase; pig, pigment; Glu, glucose, Man, manitol, MR, methylred, VP, voges proskreur
4.6. Antibiotic Susceptibility Profile of Test Bacterial Pathogens
| Antibiotic (ug) | Escherichia coli | Klebsiella pnuemoniae | Micrococcus luteus | Clostridium difficile |
|---|---|---|---|---|
| Ciprofloxacin (10) | ++ | ++ | ++ | ++ |
| Gentamycin (10) | + | ++ | - | ++ |
| Streptomycin (30) | - | + | - | ++ |
| Nalidixic acid (30) | + | - | - | ++ |
| Ampicillin (30) | - | ++ | ++ | ++ |
| Erythromycin (30) | - | ++ | ++ | ++ |
| Cefalexin (10) | - | - | - | ++ |
| Ofloxacin (5) | + | ++ | ++ | ++ |
| Augmentin (30) | - | - | - | ++ |
| Reflacine (10) | - | ++ | - | + |
a ++, resistance; +, intermediate; -, sensitive
4.7. Antibacterial Susceptibility Pattern of Multidrug-Resistant Pathogens to Newbouldia laevis Silver Nanoparticles, Citrus limon Juice Extract Silver Nanoparticles, and Plant Extract Cocktail-Mediated Silver Nanoparticles Singly and in Combination with Ampicillin
| Zones of Inhibition (mm) (n = 3) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Isolates | CAgNPs | NAgNPs | PAgNPs | CAgNPs + A | NAgNPs + A | PAgNPs + A | AgNO3 | C-N Extract |
| Escherichia coli | 26.5 A ± 3.54 | 22.0 B ± 0.00 | 24.5 C ± 3.54 | 31.0 D ± 1.41 | 24.0 C ± 0.00 | 34.0 D ± 1.41 | 19.0 E ± 0.00 | 0.0 F ± 0.00 |
| Micrococcus luteus | 23.0 E ± 4.24 | 22.0 E ± 0.00 | 24.0 B ± 1.41 | 29.5 A ± 0.71 | 25.0 C ± 0.00 | 40.5 D ± 0.71 | 18.0 D ± 0.00 | 0.0 F ± 0.00 |
| Klebsiella pnuemoniae | 28.0 D ± 1.41 | 21.0 B ± 0.00 | 21.5 B ± 0.71 | 27.0 A ± 1.41 | 23.0 C ± 0.00 | 29.0 D ± 1.41 | 20.0 E ± 0.00 | 0.0 F ± 0.00 |
| Clostridium difficile | 28.0 A ± 2.83 | 20.0 F ± 0.00 | 18.0 E ± 5.66 | 31.0 D ± 1.41 | 24.0 B ± 0.00 | 31.0 D ± 1.41 | 18.0 G ± 0.00 | 0.0 H ± 0.00 |
Abbreviations: CAgNPs, Citrus limon juice extract nanosilver; NAgNPs, Newbouldia laevis extract nanosilver; PAgNPs, C. limon juice and N. laevis extract nanosilver; CAgNPs + A, C. limon juice extract nanosilver + ampicillin; NAgNPs + A, N. laevis extract nanosilver + AMP; PAgNPs + A, C. limon juice and N. laevis extract nanosilver + AMP; C-N, C. limon juice + N. laevis extract; n, number of replicates
a Means with different capital letters (A - H) in superscript differ significantly according to the Duncan Multiple Range Test (DMRT) P ≤ 0.05.
b Values are



